-
Researchers hope leaders can use these data to decide what resources to devote to ethics consultation.
-
Numerous real-life examples of artificial intelligence in healthcare already pose difficult ethical questions: Informed consent, patient privacy, transparency, allocation, and safety are a few. The authors of a recent paper argued artificial intelligence-related ethics training should begin in medical school.
-
Despite ongoing efforts to address disparities in Alzheimer’s disease and dementia care, much work remains. The authors of a recent report identified some of the barriers diverse populations are facing in accessing and receiving dementia care.
-
The first new Alzheimer’s drug to be approved in almost 20 years has sparked a major ethical controversy, leading to protest resignations, criticism, qualifying statements, and even calls for investigations.
-
Usually, there is plenty of time for patients or families to decide if they want to be involved in a clinical trial, and there is adequate time for a thorough informed consent process. It’s a bit different in the ICU.
-
Ethical questions on organ transplantation have focused mainly on resource allocation — access to transplantation and prioritization of donor organs. A recent analysis revealed few consults were called for questions about appropriate resource allocation.
-
Ethics consults called by surgical specialties differ somewhat from consults called by other hospital specialties.
-
Chaplains often serve on ethics committees, as ethics consultants, and as institutional review board members. Yet there are no standardized ethics curricula in Clinical Pastoral Education programs.
-
Supporting families faced with making critical decisions for incapacitated loved ones is a core ethical duty for ICU clinicians. Yet little is known about family characteristics that predict their dissatisfaction with support during decision-making.
-
Updated guidelines offer specific recommendations for embryo research, stem cell embryo models, organoids, chimeras, germline genome editing, and mitochondrial replacement techniques. Public support for controversial research is an overarching goal.